| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFODERIV | Sep 16 | MPLAN | 12,394 | $0.00 | —? |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Sep 16 | SPLAN | 12,394 | $16.33 | $202K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Sep 16 | MPLAN | 12,394 | $9.88 | $122K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFODERIV | Aug 18 | MPLAN | 31,031 | $0.00 | —? |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFODERIV | Aug 17 | MPLAN | 2,876 | $0.00 | —? |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFODERIV | Aug 17 | MPLAN | 37,945 | $0.00 | —? |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Aug 18 | SPLAN | 31,031 | $20.05 | $622K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Aug 18 | MPLAN | 31,031 | $9.88 | $307K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Aug 17 | SPLAN | 3,749 | $19.94 | $75K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Aug 17 | SPLAN | 37,945 | $19.85 | $753K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Aug 17 | MPLAN | 2,876 | $9.88 | $28K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Aug 17 | MPLAN | 37,945 | $9.88 | $375K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Jun 10 | F | 138 | $13.10 | $2K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | May 21 | A | 39,900 | $0.00 | — |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFODERIV | May 7 | MPLAN | 18,606 | $0.00 | —? |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | May 7 | SPLAN | 18,606 | $24.12 | $449K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | May 7 | MPLAN | 18,606 | $9.88 | $184K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFODERIV | May 6 | MPLAN | 47,000 | $0.00 | —? |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | May 6 | SPLAN | 8,900 | $22.57 | $201K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | May 6 | SPLAN | 9,219 | $21.37 | $197K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | May 6 | SPLAN | 2,700 | $20.76 | $56K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | May 6 | SPLAN | 12,347 | $19.28 | $238K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | May 6 | SPLAN | 13,834 | $18.55 | $257K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | May 6 | MPLAN | 47,000 | $8.04 | $378K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Apr 30 | SPLAN | 8,457 | $13.23 | $112K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Apr 29 | SPLAN | 8,458 | $13.09 | $111K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Apr 2 | SPLAN | 1,780 | $17.57 | $31K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Apr 2 | SPLAN | 6,200 | $17.02 | $106K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Apr 1 | SPLAN | 7,479 | $16.83 | $126K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Apr 1 | SPLAN | 500 | $15.86 | $8K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFODERIV | Mar 28 | M | 24,200 | $0.00 | —? |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Mar 28 | F | 8,241 | $13.89 | $114K |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Mar 28 | M | 24,200 | — | — |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFODERIV | Feb 26 | A | 105,000 | $0.00 | —? |
| Avalo Therapeutics, Inc. | AVTX | Christopher Ryan SullivanCFO | Dec 10 | F | 155 | $4.10 | $636 |